Intensive Blood Pressure Lowering and Risk of Diabetes: Friend or Foe?

Hypertension. 2020 Feb;75(2):293-294. doi: 10.1161/HYPERTENSIONAHA.119.14050. Epub 2019 Dec 23.

Authors

Milad Nazarzadeh^{1

2

3}, Kazem Rahimi^{1

2

4}

Affiliations

¹ From the Deep Medicine, Oxford Martin School (M.N., K.R.), University of Oxford, United Kingdom.
² The George Institute for Global Health (M.N., K.R.), University of Oxford, United Kingdom.
³ The Collaboration Center of Meta-Analysis Research, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran (M.N.).
⁴ NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, United Kingdom (K.R.).

PMID: 31865792
DOI: 10.1161/HYPERTENSIONAHA.119.14050

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antihypertensive Agents
Blood Pressure / drug effects
Blood Pressure Determination*
Diabetes Mellitus*

Substances

Antihypertensive Agents

Grants and funding